Potential of Vγ9Vδ2T cells in tuberculosis: integration of innate and adaptive immunity for vaccine development
PeerJ · 04.03.2026 · 14 · e20904
DOI: 10.7717/peerj.20904 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 04.03.2026. Verfasst von Dalin Di und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Shandong Second Medical University; Key Laboratory of Immune Microenvironment and Inflamm…. Hauptthemen laut MEDLINE: Immunity, Innate, Adaptive Immunity, Mycobacterium tuberculosis, Tuberculosis Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Development Plan of Shandong Medical and Health Science, Scientific Research Plan of Weifang Health Commission, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis that poses major global health challenges. The Bacillus Calmette–Guérin (BCG) vaccine provides only limited protection against TB in adults and the current therapeutic regimens for TB are constrained by prolonged treatment cycles and the emergence of drug-resistant strains. Consequently, the role of Vγ9Vδ2 T cells in anti-TB immunity has increasingly garnered attention. These nonconventional T lymphocytes rapidly recognize Mtb -infected cells and exert effector functions through a unique T-cell receptor that directly recognizes phosphorylated antigens independent of the major histocompatibility complex. Vγ9Vδ2 T cells mediate direct cytotoxicity against infected cells and coordinate with other immune components to strengthen the host defense against TB. These distinctive attributes highlight the potential of Vγ9Vδ2 T cells as targets in novel TB vaccine strategies. The current understanding of Vγ9Vδ2 T cell-mediated immunity to Mtb , recent advances in TB vaccine research, and prospective directions for future investigation are synthesized in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Shandong Second Medical University; Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, Shandong…
- Department of Respiratory Critical Care Medicine, Weifang No. 2 People's Hospital, Weifang, Shandong Province, China.
- Ultrasound Medicine Department, Weifang No. 2 People's Hospital, Weifang, Shandong Province, China.
- Department of Rheumatology and Immunology, Weifang No. 2 People's Hospital, Weifang, Shandong Province, China.
Förderung
- Science and Technology Development Plan of Shandong Medical and Health Science
- Scientific Research Plan of Weifang Health Commission
- Natural Science Foundation of Shandong Province
Zitieren
APA
Di, D., Gao, C., Deng, Y., Li, Y., & Zhang, Y. (2026). Potential of Vγ9Vδ2T cells in tuberculosis: integration of innate and adaptive immunity for vaccine development. PeerJ, 14, e20904. https://doi.org/10.7717/peerj.20904
Vancouver
Di D, Gao C, Deng Y, Li Y, Zhang Y. Potential of Vγ9Vδ2T cells in tuberculosis: integration of innate and adaptive immunity for vaccine development. PeerJ. 2026;14:e20904. doi:10.7717/peerj.20904
BibTeX
@article{Di2026,
author = {Di, Dalin and Gao, Chun'e and Deng, Yonggen and Li, Yuxia and Zhang, Yanyan},
title = {Potential of Vγ9Vδ2T cells in tuberculosis: integration of innate and adaptive immunity for vaccine development},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e20904},
doi = {10.7717/peerj.20904}
}
EUVIMED